06:29 AM EDT, 04/25/2024 (MT Newswires) -- AstraZeneca ( AZN ) reported Q1 core earnings Thursday of $2.06 per diluted share, up 7% from a year earlier.

Analysts polled by Capital IQ expected $1.93.

Revenue for the quarter ended March 31 was $12.68 billion, up from $10.88 billion a year earlier.

Analysts surveyed by Capital IQ expected $11.83 billion.

The company's shares were up 6% in recent Thursday premarket activity.

Price: 75.36, Change: +4.16, Percent Change: +5.84